Condition
Acne clinical trials and research
As of November 12, 2026, Find a Trial lists 12 Acne clinical trials that are recruiting, at sites in 11 countries (most in United States (4), Australia (2), Canada (2)). 1 was first registered in the last 30 days. By phase: Phase 1/2 (2), Phase 1 (1), Phase 2 (1), Phase 4 (1). There are also 18 NIH-funded research projects on Acne, with $13.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12Clinical trials
- 18NIH research projects
- 1New in 30 days
- 11Countries
Newest Acne clinical trials
All recruiting trials (12)
-
Adapalene/Clindamycin Gel in Vietnamese Acne Patients
This study tests how safe and tolerable and how well Klenzit-C works when used in routine care by Vietnamese patients aged 12 and up with mild to moderate acne.
-
Skincare regimen for mild to moderate acne in people with sensitive skin
A 4-week test will check if a skincare regimen helps with mild to moderate acne in adults with sensitive skin.
-
Engineered Lactobacillus reuteri cream with zinc sulfate–tannic acid MPN coating for acne
This trial will test whether a topical cream containing engineered Lactobacillus reuteri with a zinc sulfate–tannic acid coating can reduce inflammatory acne in adults aged 18–33.
-
Probiotic drink for skin inflammation during the menopausal transition
This study will test whether a daily Lactobacillus casei Shirota probiotic drink can reduce inflammation and improve immune and skin health in women aged 40–60 going through the menopausal transition with inflammatory facial skin conditions.
-
Acne mRNA vaccine for adults with mild facial acne
This trial will test two injections of an acne mRNA vaccine versus placebo in adults 18–45 with mild facial acne to see if it's safe, triggers an immune response, and improves acne.
-
Evaluating the safety and effects of TVB-3567 in healthy individuals and those with acne
This study is testing a new drug called TVB-3567 to see how safe it is and how it works in healthy people and those with acne.
-
Treatment for various skin conditions using AVAVA technology
This study is testing a new device called AVAVA to see if it can help improve skin problems like acne, scars, and wrinkles.
-
Post-market follow-up of ChitoCare® Medical for scars, post-dermatological care, dermatitis, and acne
This project will try ChitoCare® Medical gel and spray to see if they are safe and help heal scars, skin after dermatologic procedures, dermatitis, and acne in people who use them.
-
Comparing a cosmetic product for treating facial acne in young adults
This study tests whether a new cosmetic product can help teenagers and young adults with acne when used alongside their regular acne treatment.
-
Evaluating an mRNA vaccine for treating moderate to severe acne
This study is testing a new mRNA vaccine to see if it can safely help adults aged 18 to 45 with moderate to severe acne.
-
Collecting samples from people with skin conditions and healthy volunteers
This study is collecting samples from people with different skin conditions and healthy volunteers to see how their biology differs and learn more about these conditions.
-
Cohort of patients treated for acne at Nantes University Hospital
This study is looking at first-time acne patients at Nantes University Hospital to see how different factors affect their acne and their quality of life.
NIH-funded research (18)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Acne: how skin oils, bacteria, and the immune system interact
A UC system grant is exploring how acne develops by looking at skin oils, skin bacteria, and the body’s immune response to help find new ways to prevent or treat acne.
-
Acne: how skin bacteria, fats, and immunity drive lesions
A large NIH-funded effort at UCLA/UCSD is studying how skin bacteria, fat metabolism, and the immune system interact to cause acne, with plans to translate findings into better treatments.
-
Spironolactone vs doxycycline for acne in women
A multi-center trial compares spironolactone and doxycycline to treat acne in adult women to find which works better with fewer side effects.
-
Novel endolysins to target Cutibacterium acnes for acne treatment
A small research grant is developing a highly specific enzyme therapy to kill the acne-causing bacteria without disturbing good skin or gut bacteria.
-
Th17 extracellular traps and skin bacteria in acne health
A study in people with acne aims to understand how specific skin bacteria and immune cells interact to fight acne-causing germs and how this could lead to better treatments.
-
New bacteria-targeting enzymes to fight acne
Developing species-specific enzymes to remove the acne-causing bacterium Cutibacterium acnes for people with acne.
-
How skin oils, bacteria, and the immune system cause acne
Researchers are exploring how skin oils, the bacteria on your skin, and immune cells interact in people with acne to find better treatment targets.
-
How skin oils, bacteria, and the immune system cause acne
This project looks at how skin oils, microbes, and immune cells cause acne to help people with inflammatory acne.
-
Spironolactone versus doxycycline for acne in women
This trial compares two commonly used oral acne medicines—spironolactone and doxycycline—to find which helps adult women get clearer skin with fewer side effects.
-
Understanding the Immune System's Role in Acne
This research explores how our body's immune cells fight the bacteria that cause acne, hoping to find new ways to treat it.
-
Understanding how immune responses affect acne treatment
This study is looking at how certain immune cells and bacteria related to acne work together, with the goal of finding new ways to help treat acne and improve skin health for people who struggle with it.
-
Investigating how the microbiome, fat metabolism, and immune response contribute to acne
This study is looking at how the bacteria on our skin, the way our body processes fats, and our immune system all work together to cause acne, and it's for anyone who wants to understand more about what triggers their breakouts.
-
Understanding how bacteria, fat metabolism, and the immune system contribute to acne
This study is looking at how the bacteria on your skin, the fats in your body, and your immune system all work together to cause acne, using skin samples to find out which cells and bacteria are involved, so we can better understand and treat this common skin condition.
-
Understanding acne in transgender individuals
This study is looking at how acne affects transgender people, especially those on hormone therapy, to learn more about how common and serious acne is for them and how it impacts their mental health and daily life.
-
Understanding how immune responses affect acne
This study is looking at how certain immune cells in your skin interact with the bacteria that causes acne, to find out how they can help clear up breakouts or make them worse, with the hope of discovering new ways to treat acne more effectively.
-
New oral treatment for severe acne using selective CYP26 inhibitors.
This study is testing a new pill that aims to help people with severe acne by blocking certain enzymes that break down a skin-friendly vitamin, hoping to improve acne without the usual side effects of current treatments.
-
Comparing spironolactone and doxycycline for treating acne in women
This study is looking at how well two medications, spironolactone and doxycycline, work for treating moderate to severe acne in women, and by joining, you could help find out which one might be better for your skin!
-
Understanding how specific enzymes from bacteria affect acne
This study is looking at how different types of acne-causing bacteria can affect your skin, especially by examining certain enzymes that can either make acne worse or help keep your skin healthy, with the hope of finding new ways to prevent or treat acne.
Related topics
Quick answers
How many Acne clinical trials are recruiting right now?
12, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (4 trials), Australia (2 trials), Canada (2 trials), France (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.